Generic Name and Formulations:
Lidocaine HCl (as monohydrate) 0.5mg/device; pwd for intradermal inj.
Powder Pharmaceuticals, Inc.
To provide local analgesia prior to venipuncture or peripheral IV cannulation in children.
<3 years: not recommended. 3–18 years: Use only on intact skin. Apply one 0.5mg dose to the planned procedure site 1–3 minutes before needle insertion; may repeat once at new site after initial attempt failed. Multiple administrations to same site: not recommended.
Avoid eyes, body orifices, mucous membranes or areas with a compromised skin barrier. Severe hepatic disease or pseudocholinesterase deficiency. Bleeding tendencies or platelet disorders: higher risk of superficial dermal bleeding. Pregnancy (Cat.B). Nursing mothers.
Additive effects with other local anesthetics.
Application-site reactions (eg, erythema, petechiae, edema), systemic reactions (eg, nausea, vomiting).
Single-use device (disposable, needle-free)—12